LINC02525

Across TCGA pan-cancer cohorts, LINC02525 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02525’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where LINC02525 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02525 is over-expressed in tumor, although a few such as UCEC and KIRP show the opposite, repressed pattern.

UCEC, KIRP, and COAD are the cancer types where LINC02525 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02525 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.456	<.001	6	view →
KIRP	All	All	−0.102	<.001	5	view →
COAD	All	All	+0.174	.007	4	view →
CHOL	All	II,III,IV	+0.720	.009	2	view →
LIHC	All	All	+0.276	.007	2	view →
LUSC	All	All	+0.213	.045	2	view →
LUAD	All	All	+0.060	.024	2	view →
THCA	All	All	−0.051	.007	2	view →
HNSC	All	All	+0.290	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC02525–UCEC

Open the UCEC breakdown →